Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants

Latest World Health Organization guidelines recommend weight-based nevirapine prophylaxis for all HIV-exposed infants in resource-limited settings, yet low birth weight (LBW) infants (< 2500 g) have been understudied. Using data from the NIH-funded India six-week extended-dose nevirapine (SWEN) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupte, Nikhil, Kinikar, Aarti, McIntire, Katherine N., Bhosale, Ramesh, Patil, Sandesh, Suryavanshi, Nishi, Mave, Vidya, Kulkarni, Vandana, Bollinger, Robert C., Gupta, Amita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045160/
https://www.ncbi.nlm.nih.gov/pubmed/27689883
http://dx.doi.org/10.1371/journal.pone.0162979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045160/
https://www.ncbi.nlm.nih.gov/pubmed/27689883
http://dx.doi.org/10.1371/journal.pone.0162979

Ejemplares similares